Genetic Risk of Diverticular Disease Predicts Early Stoppage of Nicorandil-Reference-Cited by-同舟云学术

Genetic Risk of Diverticular Disease Predicts Early Stoppage of Nicorandil

Published:2020-07-10 Issue:6 Volume:108 Page:1171-1175
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Noyes James D.¹,Mordi Ify R.¹,Doney Alexander S.²,Palmer Colin N. A.²,Pearson Ewan R.²,Lang Chim C.¹

Affiliation:

1. Division of Molecular & Clinical Medicine School of Medicine University of Dundee Dundee UK

2. Population Health and Genomics School of Medicine University of Dundee Dundee UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1941

Reference19 articles.

1. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

2. Medicines and Healthcare products Regulatory Agency.Nicorandil (Ikorel): now second‐line treatment for angina ‐ risk of ulcer complications (2016). Accessed February 15 2020.

3. Diverticular fistulation is associated with nicorandil usage

4. SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

5. A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I–Converting Enzyme Inhibitors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic, epigenetic and environmental factors in diverticular disease: systematic review;BJS Open;2024-05-08

2. Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities;Briefings in Bioinformatics;2023-11-22

3. A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics;Clinical Pharmacology & Therapeutics;2022-01-17

4. Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs;Diseases;2021-08-12

5. Nicorandil‐induced colovesical fistula in a patient with diverticular disease;Clinical Case Reports;2021-02-10